Company / Cash per Share
MBX Biosciences, Inc. Cash per Share History
FY2023-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Cash per Share
$4.64
FY2024
5-year range
$4.64 / $29.96
FY2023-FY2024
Trend
-84.5%
vs FY2023
Sector context
#45 of 205
Health Care
What the data says
MBX Biosciences, Inc.'s cash per share of $4.64 is higher than 78% of companies in the Health Care sector (FY2024).
Based on SEC 10-K filings.
4.64 in FY2024. Top quartile in the Health Care sector.
Health Care sector context is included.
Cash per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Top 22% in Health CareTop 22% of 205This company $4.64 Sector average $72.93
▼
-93.6% below sector average
Key checks
Key Insights
- In FY2024, cash per share decreased 84.5% year-over-year.
- Ranks #45 out of 205 companies in the Health Care sector.
Company context
Key Data Points
- Altman Z-Score 9.64 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Cash per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2024 | $4.64 | -84.5% |
| FY2023 | $29.96 | - |
As of FY2024 · SEC 10-K · Updated Feb 28, 2026